Abstract Title:

Synbiotics decrease the incidence of septic complications in patients with severe SIRS: a preliminary report.

Abstract Source:

Dig Dis Sci. 2009 May;54(5):1071-8. Epub 2008 Aug 23. PMID: 18726154

Abstract Author(s):

Kentaro Shimizu, Hiroshi Ogura, Miki Goto, Takashi Asahara, Koji Nomoto, Masami Morotomi, Asako Matsushima, Osamu Tasaki, Kieko Fujita, Hideo Hosotsubo, Yasuyuki Kuwagata, Hiroshi Tanaka, Takeshi Shimazu, Hisashi Sugimoto

Abstract:

The purpose of this study was to evaluate if synbiotic therapy can correct the deteriorated gut flora and environment in patients with severe systemic inflammatory response syndrome (SIRS). Twenty-nine SIRS patients, who fulfilled a serum C-reactive protein (CRP) level >10 mg/dl, received synbiotics (Bifidobacterium breve, Lactobacillus casei, and galactooligosaccharides) (S group) and were compared with previous observations in 26 patients without synbiotics (NS group). Analysis of fecal flora confirmed that patients in the S group had significantly greater levels of beneficial Bifidobacterium, Lactobacillus, and total organic acids (particularly short-chain fatty acids) than those in the NS group. The incidence of infectious complications such as enteritis, pneumonia, and bacteremia was significantly lower in the S group than in the NS group. Synbiotics maintain the gut flora and environment and decrease the incidence of septic complications in patients with severe SIRS. Further randomized controlled study is necessary to determine the effects of synbiotics.

Print Options


This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.